Predictions
Perion Network Ltd.
Start price
Target price
Perf. (%)
€21.07
25.04.22
25.04.22
€23.00
25.04.23
25.04.23
53.49%
25.04.23
25.04.23
Could be worthwhile Investment >10% per year
Innovative
Some uniques
Hecla Mining Corp.
Start price
Target price
Perf. (%)
€5.45
24.04.22
24.04.22
€6.00
24.04.23
24.04.23
2.11%
25.04.23
25.04.23
Could be worthwhile Investment >10% per year
Capable Management
Lands End Inc.
Start price
Target price
Perf. (%)
€14.10
24.04.22
24.04.22
€6.00
24.04.23
24.04.23
-51.42%
25.04.23
25.04.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Advantest Corp.
Start price
Target price
Perf. (%)
€61.26
24.04.22
24.04.22
-
24.04.23
24.04.23
30.10%
25.04.23
25.04.23
High dividend yield expected
2G Energy AG
Start price
Target price
Perf. (%)
€113.40
22.04.22
22.04.22
€130.00
22.04.23
22.04.23
-11.29%
02.05.22
02.05.22
Top 10 in its market
Revenue growth >5% per year expected
Sustainability is very important
Significant cyclical dependencies
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€8.69
22.04.22
22.04.22
-
22.04.23
22.04.23
3.54%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Helma Eigenheimbau AG
Start price
Target price
Perf. (%)
€51.60
21.04.22
21.04.22
-
21.04.25
21.04.25
-99.42%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Deutsche Rohstoff AG
Start price
Target price
Perf. (%)
€27.20
21.04.22
21.04.22
-
21.04.25
21.04.25
23.16%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
21.04.22
21.04.22
-
21.04.23
21.04.23
4.15%
01.05.22
01.05.22
Risky Investment
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€86.00
20.04.22
20.04.22
€100.00
20.04.23
20.04.23
-45.77%
04.07.22
04.07.22
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
GCP Applied Technologies Inc
Start price
Target price
Perf. (%)
€28.80
19.04.22
19.04.22
€25.00
19.04.23
19.04.23
14.58%
20.04.23
20.04.23
Probably not worthwhile Investment
Curis Inc.
Start price
Target price
Perf. (%)
€1.14
19.04.22
19.04.22
-
19.04.23
19.04.23
-21.19%
01.05.22
01.05.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.99
19.04.22
19.04.22
-
12.04.24
12.04.24
-68.19%
12.04.24
12.04.24
Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€3.20
19.04.22
19.04.22
-
12.04.26
12.04.26
-88.73%
16.02.24
16.02.24
Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€3.20
18.04.22
18.04.22
-
18.04.23
18.04.23
-10.28%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Allkem Ltd.
Start price
Target price
Perf. (%)
€9.20
18.04.22
18.04.22
€12.00
18.04.23
18.04.23
-12.18%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Overstock.com
Start price
Target price
Perf. (%)
€35.46
17.04.22
17.04.22
-
17.04.23
17.04.23
-10.60%
30.04.22
30.04.22
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Commtouch Software
Start price
Target price
Perf. (%)
€2.58
17.04.22
17.04.22
-
17.04.23
17.04.23
-92.06%
18.04.23
18.04.23
Risky Investment
Homology Medicines Inc
Start price
Target price
Perf. (%)
€1.86
17.04.22
17.04.22
-
17.04.23
17.04.23
-49.96%
18.04.23
18.04.23
Probably not worthwhile Investment
Tellurian Inc
Start price
Target price
Perf. (%)
€5.75
17.04.22
17.04.22
-
17.04.23
17.04.23
-70.84%
22.01.23
22.01.23
Probably not worthwhile Investment
Biofrontera AG ADR
Start price
Target price
Perf. (%)
€2.14
16.04.22
16.04.22
€1.00
16.04.23
16.04.23
-28.04%
30.04.22
30.04.22
Probably not worthwhile Investment
High valuation
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Hexatronic Group AB
Start price
Target price
Perf. (%)
€8.55
16.04.22
16.04.22
€4.00
16.04.23
16.04.23
-10.10%
30.04.22
30.04.22
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation